QMB Cancer Programme

Download the meeting schedule as a PDF.

Thursday morning

Session 1 Targets for Cancer Drugs - Joint With Drug Discovery Satellite

• Peter Vogt (San Diego) - Cancer oncogenes
• Roger Daly (Sydney) -Cancer phenotyping by phosphoproteomic profiling.
• Peter Shepherd (Auckland) - Targeting PI 3-kinase
• Gary Parkinson, London (Telomerase)

Session 2 Cancer Drugs cont.

• Lai Ming Ching (Auckland) - DMXAA story
• +selections from abstracts

Lunch

Session 3 Tumour proteases, metastasis, tumour diagnosis etc

• Charles Craik (UCSF, San Francisco, USA) - tumour proteolytic activity and imaging
• Parry Guilford (Otago) - diagnostic bladder cancer test
• +selection from abstracts

Session 4 Cancer Immunology (Joint with drug discovery satellite)

• Richard G Vile (Mayo Clinic, Minnesota, USA) - cancer immunology
• Rod Dunbar (Auckland) - cancer immunology
• Sarah Young (Otago) - cancer immunology

Friday Morning

Session 5 Cell immortalisation in cancer

• Roger Reddel (CMRI, Sydney)
• Scott Cohen (CMRI, Sydney)
• Tracy Bryan (CMRI, Sydney)

Session 6 Oncogenes, tumour suppressor genes, and cell cycle control

• Antony Braithwaite (Sydney/Otago)
• Philip Kaldis (Singapore)
• Mike Eccles (Otago)

Lunch

Session 7 Melanoma Molecular Biology

• Bruce Baguley (Auckland)
• Nick Hayward (Queensland)
• Aaron Jeffs (Otago)

Session 8 Cancer gene networks, gene expression and gene regulation

• Cristin (Cris) Print (Auckland)
• David Bowtell (Melbourne)
• Nicole Cloonan (Queensland)
• +Selections from abstracts and student presentations

Website design by Webcentre Ltd